HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
P/S ratio for HeartBeam, Inc. (BEAT)
P/S ratio as of 2023: 0.00
According to HeartBeam, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.00. At the end of 2022 the company had a P/S ratio of 0.00.
P/S ratio history for HeartBeam, Inc. from 2003 to 2023
P/S ratio at the end of each year
| Year | P/S ratio |
|---|---|
| 2023 | 0.00 |
| 2022 | 0.00 |
| 2021 | 0.00 |
| 2020 | 0.00 |
| 2019 | 0.00 |
| 2018 | 5.35 |
| 2017 | 3.17 |
| 2016 | 3.00 |
| 2015 | 1.77 |
| 2014 | 1.59 |
| 2013 | 1.57 |
| 2012 | 0.51 |
| 2011 | 0.49 |
| 2010 | 0.94 |
| 2009 | 1.00 |
| 2008 | 3.75 |
| 2007 | 0.71 |
| 2006 | 1.52 |
| 2005 | 1.62 |
| 2004 | 2.27 |
| 2003 | 5.41 |